Bio News
Siemens Healthineers and Novo are partnering to raise awareness of fatty liver disease and expand diagnosis.
The two companies will pursue earlier assessment of patients with metabolic dysfunction-associated steatohepatitis (MASH) and expand access to blood testing.
Siemens Healthineers offers the ELF blood test, which is less invasive than a liver biopsy.
BIOBOOK TEAM
biobookmedia@biobook.co.krParagon Spin-Off Velaris Goes Public Through Reverse Merger With Alaunos
Syndax halts development of Niktimvo for pulmonary fibrosis; shares plunge 17%
BioNTech’s mRNA Cancer Vaccine Misses Primary Endpoint for Progression-Free Survival in Phase 3 Trial
Roche Signs $1.6 Billion Deal With China’s Rona for ALK7 Obesity Drug
Formycon and Zydus’ Keytruda Biosimilar Is First to Be Accepted for FDA Review
Pfizer Signs $500 Million Protein Degrader Deal With Enodia
